We used the cell lines to mimic the enhancement of PERK activity to levels observed in tumor patients and determined its effects on tumor cells, thus enabling a critical evaluation of the role of PERK signaling in medulloblastoma cell migration and invasion. The gene discussed is EIF2AK3; the disease is medulloblastoma.